1 – 20 of 45
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Antiviral tablettbehandling av covid-19 – ett värdefullt tillskott
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
COVID-19 hospitalization outcomes in adults by HIV status; a nation-wide register-based study
(
- Contribution to journal › Article
-
Mark
The molecular epidemiology of HIV-1 in Sweden 1996 to 2022, and the influence of migration from Ukraine
2023) In Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 28(48).(
- Contribution to journal › Article
-
Mark
Impact of pre-antiretroviral treatment HIV-RNA on time to successful virological suppression and subsequent virological failure - two nationwide, population-based cohort studies
(
- Contribution to journal › Article
-
Mark
Cohort profile: InfCareHIV, a prospective registry-based cohort study of people with diagnosed HIV in Sweden
(
- Contribution to journal › Article
-
Mark
Plasmablasts in previously immunologically naïve COVID-19 patients express markers indicating mucosal homing and secrete antibodies cross-reacting with SARS-CoV-2 variants and other beta-coronaviruses
(
- Contribution to journal › Article
-
Mark
Longitudinal single-cell analysis of SARS-CoV-2-reactive B cells uncovers persistence of early-formed, antigen-specific clones
(
- Contribution to journal › Article
- 2022
-
Mark
Factors associated with low-level viraemia in people with HIV starting antiretroviral therapy : A Swedish observational study
(
- Contribution to journal › Article
-
Mark
Associations between HIV viremia during antiretroviral therapy and cardiovascular disease
(
- Contribution to journal › Article
-
Mark
Confirmed reinfection with SARS-CoV-2 during a pregnancy : A case report
(
- Contribution to journal › Article
-
Mark
COVID-19 in people aged 18–64 in Sweden in the first year of the pandemic : Key factors for severe disease and death
(
- Contribution to journal › Article
-
Mark
Severe COVID-19 in people 55 and older during the first year of the pandemic in Sweden
(
- Contribution to journal › Article
-
Mark
Longevity of anti-spike and anti-nucleocapsid antibodies after COVID-19 in solid organ transplant recipients compared to immunocompetent controls
(
- Contribution to journal › Article
-
Mark
A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome : No Evidence of Benefit, Supported by Epidemiology and In Vitro Data
(
- Contribution to journal › Article
- 2021
-
Mark
Associations between Plasma HIV RNA Levels and Incidence of Invasive Cancer in People with HIV after Initiation of Combination Antiretroviral Therapy
2021) In Open Forum Infectious Diseases(
- Contribution to journal › Article
-
Mark
Longitudinal Follow Up of Immune Responses to SARS-CoV-2 in Health Care Workers in Sweden With Several Different Commercial IgG-Assays, Measurement of Neutralizing Antibodies and CD4
+ T-Cell Responses.
(
- Contribution to journal › Article
-
Mark
Infection of brain pericytes underlying neuropathology of covid‐19 patients
(
- Contribution to journal › Article
-
Mark
Association of cardiometabolic risk factors with hospitalisation or death due to COVID-19 : population-based cohort study in Sweden (SCAPIS)
(
- Contribution to journal › Article
-
Mark
COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19) : a structured summary of a study protocol for a randomised controlled trial
(
- Contribution to journal › Letter
- 2020
-
Mark
Low-Level Viremia during ART and the Risk of Death, AIDS, and Serious Non-AIDS-events
(
- Contribution to conference › Abstract